Washington Trust Advisors’s Twist Bioscience TWST Stock Holding History

Washington Trust Advisors’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-32	Closed	-$900	–	691
2025 Q3	$900	Hold	32	–	–	﹤0.01%	680
2025 Q2	$1.18K	Hold	32	–	–	﹤0.01%	623
2025 Q1	$1.26K	Hold	32	–	–	﹤0.01%	622
2024 Q4	$1.49K	Hold	32	–	–	﹤0.01%	629
2024 Q3	$1.45K	Hold	32	–	–	﹤0.01%	647
2024 Q2	$1.58K	Hold	32	–	–	﹤0.01%	639
2024 Q1	$1.1K	Hold	32	–	–	﹤0.01%	651
2023 Q4	$1.18K	Hold	32	–	–	﹤0.01%	655
2023 Q3	$649	Hold	32	–	–	﹤0.01%	666
2023 Q2	$655	Hold	32	–	–	﹤0.01%	650
2023 Q1	$483	Hold	32	–	–	﹤0.01%	769
2022 Q4	$762	Hold	32	–	–	﹤0.01%	770
2022 Q3	$1K	Hold	32	–	–	﹤0.01%	893
2022 Q2	$1K	Hold	32	–	–	﹤0.01%	920
2022 Q1	$2K	Hold	32	–	–	﹤0.01%	961
2021 Q4	$2K	Buy	+32	New	+$3.29K	﹤0.01%	967

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Washington Trust Advisors's TWST Position: Q4 2025 in Review

Washington Trust Advisors sold out of Twist Bioscience (TWST) in Q4 2025, closing a stake of 32 shares — an estimated $900 sold.

Washington Trust Advisors first reported a position in TWST in Q4 2021 and held it in 16 quarters. The position peaked at $2K in Q1 2022. 243 funds tracked by Wall St. Rank hold TWST as of Q4 2025.

Washington Trust Advisors reported no remaining Twist Bioscience position as of Q4 2025 after selling out during the quarter.
Washington Trust Advisors sold 32 Twist Bioscience shares in Q4 2025, an estimated $900.
Washington Trust Advisors first reported a position in Twist Bioscience in Q4 2021 and held it in 16 quarters.
Washington Trust Advisors's Twist Bioscience position peaked at $2K in Q1 2022.
243 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2025.

Based on Washington Trust Advisors's 13F filing for Q4 2025, filed 3 Feb 2026.